These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 20132195
21. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, Vazina A, Gupta A, Bastian PJ, Perrotte P, Sagalowsky AI, Schoenberg M, Lerner SP. J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631 [Abstract] [Full Text] [Related]
22. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ. Ann Surg Oncol; 2011 Jul; 18(7):2018-25. PubMed ID: 21246405 [Abstract] [Full Text] [Related]
23. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy. Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF. BJU Int; 2011 Sep; 108(5):687-92. PubMed ID: 21087453 [Abstract] [Full Text] [Related]
24. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y, Lotan Y, Isbarn H, Capitanio U, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Tilki D, Dinney CP, Lerner SP, Schoenberg M, Volkmer BG, Sagalowsky AI, Shariat SF. J Urol; 2010 Jun; 183(6):2165-70. PubMed ID: 20399473 [Abstract] [Full Text] [Related]
26. Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens. Resnick MJ, Bergey M, Magerfleisch L, Tomaszewski JE, Malkowicz SB, Guzzo TJ. BJU Int; 2011 Jan; 107(1):46-52. PubMed ID: 20880163 [Abstract] [Full Text] [Related]
28. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Shariat SF, Karakiewicz PI, Palapattu GS, Amiel GE, Lotan Y, Rogers CG, Vazina A, Bastian PJ, Gupta A, Sagalowsky AI, Schoenberg M, Lerner SP. Clin Cancer Res; 2006 Nov 15; 12(22):6663-76. PubMed ID: 17121885 [Abstract] [Full Text] [Related]
29. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M. Eur Urol; 2013 Apr 15; 63(4):739-44. PubMed ID: 23079053 [Abstract] [Full Text] [Related]
31. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. J Urol; 2001 Jul 15; 166(1):19-23. PubMed ID: 11435814 [Abstract] [Full Text] [Related]
32. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M. Ann Acad Med Stetin; 2000 Jul 15; 46():217-29. PubMed ID: 11712306 [Abstract] [Full Text] [Related]
34. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy. Harada K, Sakai I, Hara I, Eto H, Miyake H. Int J Urol; 2005 Mar 15; 12(3):250-5. PubMed ID: 15828951 [Abstract] [Full Text] [Related]
35. Surgical factors influence bladder cancer outcomes: a cooperative group report. Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, Crawford ED. J Clin Oncol; 2004 Jul 15; 22(14):2781-9. PubMed ID: 15199091 [Abstract] [Full Text] [Related]
36. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. Solsona E, Iborra I, Rubio J, Casanova J, Almenar S. BJU Int; 2004 Dec 15; 94(9):1258-62. PubMed ID: 15610101 [Abstract] [Full Text] [Related]
37. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M. BJU Int; 2016 Feb 15; 117(2):272-9. PubMed ID: 25381844 [Abstract] [Full Text] [Related]